Skip to main content

Table 2 MT1G hypermethylation in PTC ― univariate associations with clinicopathological characteristics (OR 1 and 95% CI)

From: Metallothionein 1G functions as a tumor suppressor in thyroid cancer through modulating the PI3K/Akt signaling pathway

Variable

OR1

95% CI

Pvalue

Gender

0.99

0.48-2.01

0.97

Age2

0.92

0.63-1.36

0.69

Tumor invasion

0.71

0.38-1.36

0.31

Lymph node metastasis

2.14

1.12-4.07

0.02*

Tumor stage3

0.97

0.67-1.40

0.87

Tumor size4

1.11

0.78-1.58

0.55

Tumor recurrence

1.19

0.47-2.99

0.71

  1. 1 OR: odds ratio with 95% confidence interval.
  2. 2Age (≤30y; 30-50y; 50-70y; >70y).
  3. 3Tumor stage (I, II, III, IV).
  4. 4Tumor size (≤1 cm; 1–3 cm; 3–5 cm; >5 cm).
  5. *Significant at P <0.05.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us